INMNasdaqPharmaceutical PreparationsFiscal year ends June 30
InMed Pharmaceuticals Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 9, 2026
$1.37+0.05 (+3.44%)
Close on Oct 19, 2026
- Market cap
- $6.42M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
InMed Pharmaceuticals has not reported a dividend
No dividend per share appears in InMed Pharmaceuticals's annual filings since fiscal 2019.